Urologic Oncology Seminars and Original Investigations · 2011 · 87 citations · 29 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologyProstate DiseaseCancer ProgressionMalignant NeoplasmsProstate CancerTargeted Cancer TherapyTargeted TherapyTyrosine Kinase InhibitorsAdvanced Prostate Cancer TherapyCastration-resistant Prostate Cancer TherapyEgfr InhibitionErlotinib TherapyHer2 InhibitorsPhase Ii InvestigationTherapeutic Tyrosine Kinase InhibitorsTyrosine Kinase Inhibitor Therapy
29
Howard I. Scher, Susan Halabi, Ian F. Tannock et al. · Journal of Clinical Oncology · 2008 · 2.2K citations · Full text